Milner Institute announced as finalist for OBN Award
We are proud to announce that the Milner Therapeutics Institute has been shortlisted for a 2021 OBN Award in the category for Most Impactful Business Support Organisation. The OBN Awards, now in their 13th year, celebrate individuals and life sciences companies that...
Milner collaboration uncovers promising target for new drug development
Research in the Tzelepis lab, in collaboration with scientists from the Wellcome Sanger Institute and Harvard University, has identified a protein that plays a key role in transforming normal tissue to cancerous, as a possible target for drug development. The...
Milner group use combination of computational biology and machine learning to create comprehensive map of proteins involved in SARS-CoV-2 infection
Namshik Han’s group at the Milner Therapeutics Institute, have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19 clinical trials. In a study published this week in Science Advances,...
Connect: Health Tech is launched
We are excited to announce that the University of Cambridge has launched the Connect: Health Tech microsite and online community platform, as part of the new University Enterprise Zone (UEZ) initiative. The delivery team behind Connect: Health Tech is the Milner...